Bladder Tumor
Conditions
Interventions
test group:cryoablation treatment
controll group:drug treatment
Sponsors
Huashan Hospital of Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) patients that clinical diagnosis of bladder tumor, clinical staging for T1, T2 phase; (2) the number of tumors = 3; (3) the largest diameter of the tumor = 3cm; (4) aged between 18 to 85 years old male or female; (5) voluntarily participate and sign informed consent to cooperate with the patients who completed the whole trial process.
Exclusion criteria
Exclusion criteria: (1) accompanied by bacteremia, toxemia and other serious infectious diseases; (2) severe coagulation dysfunction; (3) suffering from severe heart, brain, lung, liver, kidney and other diseases, can not tolerate surgery; (4) patients with other malignancies; (5) preoperative assessment of distant metastases or pelvic lymphadenopathy; (7) pregnant or lactating women; (8) the merger of drugs, including systemic anti-tumor drugs and immunosuppressive agents; (9) participate in other clinical trials within 3 months; (10) Researchers believe that there are other circumstances that are not appropriate for the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical effect rate; | — |
Countries
China
Contacts
Public ContactHaowen Jiang
Huashan Hospital of Fudan University
Outcome results
None listed